EPIVAX THERAPEUTICS, INC.
Improving Life Through Precision Medicine
ABOUT US
EpiVax Therapeutics ('EVT'), an emerging biotechnology company, employs a world-leading technology developed over two decades, to design vaccines that activate the body’s T cells. EVT’s pipeline includes a COVID-19 vaccine and a personalized bladder cancer vaccine.
